Method sharpens proteome-wide view of structural changes
Protein structure underlies function, and shifts in that structure can reveal changes in cell signaling, metabolism, stress responses and genetic variation. But tracking such structural changes across the proteome remains a challenge. Luise Nagel of the University of Cologne and colleagues in Switzerland developed a method using limited proteolysis coupled with mass spectrometry, or LiP–MS, to distinguish true structural changes from confounding factors such as protein abundance. They published their findings in Molecular & Cellular Proteomics.
LiP–MS works by probing protein structures with proteinase K, or PK, a protease whose digestion patterns shift when proteins change shape. The team validated their method using samples from budding yeast, fission yeast and human cerebrospinal fluid.
To isolate structural signals, they built a framework to remove unwanted variation (RUV) from LiP–MS data. The framework outperformed other approaches by separating structural changes from effects such as protein abundance, posttranslational modifications and alternative splicing. Beyond LiP–MS, the framework could apply to other peptide-centric structural proteomics methods, including fast photochemical oxidation of proteins and molecular painting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Differences in pili structure modulate bacterial behavior
Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.